You just read:

Theratechnologies Announces New Data from the Pivotal Phase III Trial of HIV Monoclonal Antibody and Long-Acting Investigational Antiretroviral Ibalizumab

News provided by

Theratechnologies Inc.

Feb 14, 2017, 19:00 ET